Developing Targeted Therapies for Leukemia

Understanding the molecular pathology of leukemia guides researchers to develop targeted treatments.

To treat leukemia, clinicians have long relied on chemotherapy and radiation therapy that kill both cancer and healthy cells. In contrast, emerging targeted therapies block molecular pathways associated with leukemia to selectively destroy cancer cells, significantly improving treatment outcomes while decreasing toxicity. 

Download this poster from Drug Discovery News to learn about the mechanisms underlying leukemia and strategies for developing targeted leukemia therapies.